Vickers Vantage Corp. I
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $138.00M |
|---|---|
| IPO Date | Jan 7, 2021 |
| CEO | Jeffrey Chi |
| Left Lead | Maxim |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 3 + 3 + 1 + 1 + 1 + 1 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Scilex |
| Deal Announced | Mar 18, 2022 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Nov 9, 2022 |
| Amendment Vote | Jun 30, 2022 |
| Closing Date | Nov 10, 2022 |
Formerly VCKA
SCLX
SCLXW
| Price | $21.13 $0.60 |
|---|---|
| Last closing price | $20.25 |
| H/L, today | $20.10 / $21.31 |
| H/L, 52-week | $1.21 / $16.90 |
| Volume, today | 15,390 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.